RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 137 filers reported holding RELAY THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $435,462 | -24.1% | 51,779 | +13.4% | 0.00% | – |
| Q2 2023 | $573,490 | -77.9% | 45,660 | -71.0% | 0.00% | -100.0% |
| Q1 2023 | $2,591,439 | -26.8% | 157,343 | -33.6% | 0.00% | -50.0% |
| Q4 2022 | $3,540,242 | -59.4% | 236,964 | -39.3% | 0.00% | -60.0% |
| Q3 2022 | $8,726,000 | +227.4% | 390,108 | +145.2% | 0.01% | +400.0% |
| Q2 2022 | $2,665,000 | -8.9% | 159,115 | +62.7% | 0.00% | 0.0% |
| Q1 2022 | $2,926,000 | -4.9% | 97,779 | -2.4% | 0.00% | 0.0% |
| Q4 2021 | $3,077,000 | +128.1% | 100,218 | +134.1% | 0.00% | 0.0% |
| Q3 2021 | $1,349,000 | -5.2% | 42,801 | +10.1% | 0.00% | 0.0% |
| Q2 2021 | $1,423,000 | +29.6% | 38,889 | +22.5% | 0.00% | 0.0% |
| Q1 2021 | $1,098,000 | +5.2% | 31,745 | +26.3% | 0.00% | 0.0% |
| Q4 2020 | $1,044,000 | +42.4% | 25,137 | +46.0% | 0.00% | 0.0% |
| Q3 2020 | $733,000 | – | 17,215 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 3,030,648 | $45,277,881 | 3.51% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $416,900,147 | 3.48% |
| Finepoint Capital LP | 714,848 | $10,680 | 3.45% |
| Nextech Invest Ltd. | 475,485 | $7,103,746 | 2.83% |
| BVF INC/IL | 3,876,021 | $57,907,754 | 2.44% |
| Integral Health Asset Management, LLC | 625,000 | $9,337,500 | 1.96% |
| EcoR1 Capital, LLC | 4,163,824 | $62,207,531 | 1.89% |
| Boxer Capital, LLC | 2,169,132 | $32,406,832 | 1.71% |
| BRANDYWINE MANAGERS, LLC | 31,807 | $475,197 | 1.66% |
| HighVista Strategies LLC | 176,521 | $2,637,224 | 1.57% |